APA

An E., Ock C., Kim T., Lee K., Han S., Im S., Kim T., Liao W., Cecchi F., Blackler A., Thyparambil S., Kim W. H., Burrows J., Hembrough T., Catenacci D. V. T., Oh D. & Bang Y. (20170427). Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

An E, Ock C-Y, Kim T-Y, Lee K-H, Han S-W, Im S-A, Kim T-Y, Liao W-L, Cecchi F, Blackler A, Thyparambil S, Kim W H, Burrows J, Hembrough T, Catenacci D V T, Oh D-Y and Bang Y-J. 20170427. Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

An E., Ock C., Kim T., Lee K., Han S., Im S., Kim T., Liao W., Cecchi F., Blackler A., Thyparambil S., Kim W. H., Burrows J., Hembrough T., Catenacci D. V. T., Oh D. and Bang Y. (20170427). Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

An E, Ock C-Y, Kim T-Y, Lee K-H, Han S-W, Im S-A, Kim T-Y, Liao W-L, Cecchi F, Blackler A, Thyparambil S, Kim W H, Burrows J, Hembrough T, Catenacci D V T, Oh D-Y and Bang Y-J. Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment. : Annals of oncology : official journal of the European Society for Medical Oncology. 20170427.